SHARE: +/-: 0.80 SEK / Bid: 10.60 SEK / Ask: 10.90 SEK / Price: 10.90 SEK / High: 11.00 SEK / Low: 10.50 SEK / Quantity: 14 406 / Turnover: 154 720 SEK / 2019-02-20 09:02 (CET)
Business Development
Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.
We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.
For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se
Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment
Copyright
© 2016 Spago Nanomedical AB.
All rights reserved
Address
Scheelevägen 22
SE-223 63 Lund, Sweden
